Yahoo Web Search

Search results

1. • 

     Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market

     Investing.com· 4 days ago

     Verona Pharma (NASDAQ: VRNA ) has announced its first quarter 2024 financial results, highlighting...

2. • 

     BofA bullish on Apogee stock, sees significant market growth potential By Investing.com

     Investing.com· 3 days ago

     Friday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...

3. • Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...

     Benzinga· 4 days ago

     PDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /

4. • Yupelri Dosage: Form, Strength, How To Use, and More

     Healthline· 6 days ago

     Yupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet ...

5. • 

     Pulmonary Function Test

     Health via Yahoo News· 4 days ago

     Healthcare providers use PFTs to: Diagnose lung conditions, such as COPD, asthma, emphysema (a form of COPD characterized by damage to the lungs' air...

6. • Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview

     GuruFocus.com via Yahoo Finance· 3 days ago

     This product is poised to be the first new inhaled treatment mechanism for Chronic Obstructive Pulmonary Disease (COPD) in over two decades, pending approval ...

7. • MemorialCare Cancer Institute Revolutionizes Prostate Cancer Treatment: Hot Water Potential Solution...

     WFRV 5 Green Bay· 6 days ago

     MemorialCare Cancer Institute at Saddleback Medical Center is the only location in Orange County – and one of only two in California – to offer a new, innovative way to treat prostate cancer ...

8. • 

     Varenicline Leads in Helping Smokers Kick the Habit, Study

     Medscape· 4 days ago

     Most smokers do successfully quit after their first attempt. Switching patients from nicotine...

9. • 

     What You Need to Know About Inhalants for Crohn's Disease

     Healthline· 4 days ago

     Inhaled corticosteroids aren’t a common treatment option for Crohn’s disease. Crohn’s disease (CD)...

10. • Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update

      FOX 4 Kansas City· 3 days ago

      $16.3 million in cash and cash equivalents at the end of Q1 2024 providing projected cash runway into Q1 2026 Third amendment made in Q1 to Cipla partnership results in the wind down of the ...